Error message

  • Deprecated function: Optional parameter $feed_nid declared before required parameter $context is implicitly treated as a required parameter in include_once() (line 1439 of /local/drupal/imat/includes/bootstrap.inc).
  • Deprecated function: Optional parameter $input declared before required parameter $form_state is implicitly treated as a required parameter in require_once() (line 12 of /local/drupal/imat/sites/all/modules/media/media.module).
×

ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE


Year of Award:
2005
Status:
Complete
Award Type:
R43
Project Number:
CA114126
RFA Number:
RFA-CA-05-006
Technology Track:
Molecular & Cellular Analysis Technologies
PI/Project Leader:
LIM, MARK
Other PI or Project Leader:
N/A
Institution:
AMBERGEN, INC
Significant advances have been made in the development of a new generation of molecularly targeted cancer drugs, many of which are only now emerging from the drug development pipeline. Examples of small molecule drugs are imatinib (Gleevec), used to treat